Related references
Note: Only part of the references are listed.A data set of variants derived from 1455 clinical and research exomes is efficient in variant prioritization for early-onset monogenic disorders in Indians
Neethukrishna Kausthubham et al.
HUMAN MUTATION (2021)
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)
Erin Rooney Riggs et al.
GENETICS IN MEDICINE (2020)
Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants
Wen Zhang et al.
CLINICA CHIMICA ACTA (2019)
Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype
Audrey A. M. Vollebregt et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2017)
Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II
A. Uttarilli et al.
CLINICAL GENETICS (2016)
Wide allelic heterogeneity with predominance of large IDS gene complex rearrangements in a sample of Mexican patients with Hunter syndrome
M. A. Alcantara-Ortigoza et al.
CLINICAL GENETICS (2016)
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase
Motomichi Kosuga et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)
H. Amartino et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2014)
Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations
Laura M. Pollard et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
LCR-initiated rearrangements at the IDS locus, completed with Alu-mediated recombination or non-homologous end joining
Junko Oshima et al.
JOURNAL OF HUMAN GENETICS (2011)
Analysis of the IDS Gene in 38 Patients with Hunter Syndrome: The c.879G>A (p.Gln293Gln) Synonymous Variation in a Female Create Exonic Splicing
Huiwen Zhang et al.
PLOS ONE (2011)
Mucopolysaccharidosis type II: an update on mutation spectrum
Roseline Froissart et al.
ACTA PAEDIATRICA (2007)
Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations
S. Alves et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Cumulative incidence rates of the mucopolysaccharidoses in Germany
F Baehner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II
T Kato et al.
JOURNAL OF HUMAN GENETICS (2005)
Characterization of Iduronate-2-sulfatase gene-pseudogene recombinations in eight patients with mucopolysaccharidosis type II revealed by a rapid PCR-based method
S Lualdi et al.
HUMAN MUTATION (2005)
Share Paper
